Tuberc Respir Dis.  2017 Jul;80(3):221-225. 10.4046/trd.2017.80.3.221.

Current Epidemiological Data on Asthma Management in South Korea from Qualitative Assessment of Asthma Management by Health Insurance Review and Assessment Service (HIRA)

• Kim SR
• Lee YC
• Sung MJ
• Bae HW

• KMID: 2385035
• DOI: http://doi.org/10.4046/trd.2017.80.3.221

Abstract

Since 2015, the Health Insurance Review and Assessment Service (HIRA) has performed annual qualitative assessments of asthma management provided by all medical institutions that care for asthma patients in Korea. According to the third report of qualitative assessment of asthma management in 2017, the assessment appears to have contributed to improving the quality of asthma care provided by medical institutions, especially primary clinics. However, there is still a gap between the ideal goals of asthma management and actual health care policies/regulations in real clinical settings, which leads to the state of standstill with respect to the quality of asthma management despite considerable efforts such as the qualitative assessment of asthma management by national agencies such as the HIRA. At this point, a harmonized approach is needed to raise the level of asthma management among several components including medical policies, efforts of academic associations such as education and distribution of the guideline for management, and reliable financial support by the government.

Keyword

Asthma; Insurance, Health; Corticosteroid; Physicians, Primary Care

MeSH Terms

Asthma*
Delivery of Health Care
Education
Financial Support
Humans
Insurance, Health*
Korea*
Physicians, Primary Care

Reference

1. Health Insurance Review and Assessment Service [Internet]. Wonju: Health Insurance Review and Assessment Service;2017. cited 2017 May 16. Available from: http://www.hira.or.kr.

2. Global Initiative for Asthma. Global strategy for asthma management and prevention [Internet]. Bethesda: Global Initiative for Asthma;2017. updated 2017. cited 2017 May 16. Available from: http://www.ginasthma.org.

3. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002; 110:58–64.

4. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007; 120:1360–1367.

5. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy. 1996; 26:Suppl 1. 1–24.

6. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006; 61:663–670.

7. Peura S, Martikainen J, Klaukka T. Use and costs of asthma medication in 1980s. Publication M: 72. Helsinki: Social Insurance Institution;1990.

8. Klaukka T, Hirvonen A, Karhula K, Peura S. Good and bad news from asthma. Asthma barometer 2004. Suom Laakaril. 2004; 42:4002–4004.